Fig. 1From: Impact of early chimerism status on clinical outcome in children with acute lymphoblastic leukaemia after haematopoietic stem cell transplantationOverall survive (OS) of study patients. a Kaplan-Meier survival plots for OS of study patients with complete donor chimerism (n = 24) in day 14 and patients with mixed chimerism (n = 32) in day 14. Study cohort: n = 56, p = 0.093. b Kaplan-Meier survival plots for OS of study patients with complete donor chimerism (n = 40) in day 21 and patients with mixed chimerism (n = 16) in day 21. Study cohort: n = 56, p = 0.150. c Kaplan-Meier survival plots for OS of study patients with complete donor chimerism (n = 43) in day 28 and patients with mixed chimerism (n = 13) in day 28. Study cohort: n = 56, p = 0.058Back to article page